These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11549771)

  • 1. Epidemiology of thrombosis in cancer.
    Rickles FR; Levine MN
    Acta Haematol; 2001; 106(1-2):6-12. PubMed ID: 11549771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
    J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S; Lindmarker P
    N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
    Baglin T; Luddington R; Brown K; Baglin C
    Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with active cancer.
    Seddighzadeh A; Shetty R; Goldhaber SZ
    Thromb Haemost; 2007 Sep; 98(3):656-61. PubMed ID: 17849056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism and cancer: risks and outcomes.
    Lee AY; Levine MN
    Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
    Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
    Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
    van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
    Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, causes, and impact of cancer-associated thrombosis.
    Pruemer J
    Am J Health Syst Pharm; 2005 Nov; 62(22 Suppl 5):S4-6. PubMed ID: 16286366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism as first manifestation of cancer.
    Piccioli A; Prandoni P
    Acta Haematol; 2001; 106(1-2):13-7. PubMed ID: 11549772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK; Huynh TM; Moseley SE; Minjarez RC; Landry GJ; Mitchell EL; Deloughery TG; Moneta GL
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.
    Verso M; Agnelli G; Ageno W; Imberti D; Moia M; Palareti G; Pistelli R; Cantone V;
    Thromb Res; 2012 Sep; 130(3):369-73. PubMed ID: 22583838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism and occult malignancy.
    Otten HM; Prins MH
    Thromb Res; 2001 Jun; 102(6):V187-94. PubMed ID: 11516452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.